Search Results
You are looking at 1 - 10 of 322 items for
- Author or Editor: ASN Staff x
- Refine by Content Type: All x
ASN Advocacy for Kidney Transplant Model Yields Success
“[In] 2012, Yale and other academic medical centers in the United States joined with the Rwandan Ministry of Health’s Human Resources for Health Program (HRH) to strengthen the country’s medical resources and increase the quantity and quality of its workforce. The HRH —a seven-year training program focused on medicine, nursing, dentistry, and health management — is led by the government of Rwanda and funded by the U.S. President’s Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention and the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
The President’s Executive Order, issued in conjunction with the Advancing American Kidney Health Initiative, calls for new payment models for kidney physicians. Here’s a brief rundown of how the Centers for Medicare and Medicaid Innovation propose they would work.
According to the statement released by the American Society of Transplantation (AST):
“The Food and Drug Administration (FDA) and the American Society of Hospital Pharmacists (ASHP) recently published data on shortages of tacrolimus, an anti-rejection medicine used to prevent rejection after organ transplantation. At the time this information was published, these shortages apply to some generic versions of tacrolimus, and dates for resolution of the shortages range from July 2019 to April 2020. Generic formulations have been evaluated by the FDA and are equivalent to brand-name (innovator) medicines. If this shortage affects your patients, we recommend discussing alternative options within your teams to devise a management strategy.
CMS is proposing to give Medicare Part D and Medicare Advantage plans the option to limit coverage of drugs in six categories — known as the “protected classes” — in a bid to lower pharmaceutical costs. The agency posted a proposed rule in the Federal Register on Nov. 30, available for public comment through Jan. 25, that would give health plans the ability to exclude protected class drugs from medication prescription lists in certain instances. The changes are estimated to save the government about $1.9 billion over 10 years and save Medicare enrollees $692 million in cost sharing.
In the first major transformation in kidney care in almost 50 years, the Trump Administration announced the Advancing the American Kidney Health initiative on July 10, 2019. The comprehensive kidney health strategy will bring sweeping changes to care for people with kidney diseases, including more choices for dialysis modalities, greater access to transplantation, and concerted support for development of innovative therapies, including artificial kidneys.
On Monday March 4th, Secretary Alex M. Azar II delivered a speech at the 6th Annual Kidney Patient Summit outlining both KidneyX and the strategic pillars of establishing an HHS-wide approach to comprehensive kidney care. ASN released a statement from ASN President Mark E. Rosenberg, MD, FASN, congratulating Secretary Azar and HHS on implementing this bold plan to better serve kidney disease patients and confirming ASN’s commitment to work together to achieve this goal.
The American Society of Nephrology (ASN) is hosting an exclusive webinar on the Advancing American Kidney Health initiative on Wednesday, July 24, 2019, from 2:00-2:45 p.m. EDT.
Hear an overview of the Executive Order launching the initiative, an overview of the forthcoming new payment models, and discuss the report from the office of Assistant Secretary of Planning and Evaluation. The webinar is free to attend.
Please see more information on telehealth in a recent Kidney News Online post by David White, the ASN Policy and Advocacy Specialist.
